EGFR and in situ carcinoma: The patients with EGFR KDD (n = 36) displayed a similar CIS (p = 0.27) and TMB (p = 0.24) compared to the patients with non‐EGFR KDDs (n = 9), although the median CIS of the EGFR KDD group was slightly higher (Figure S3, Table S3).